Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where John R. Votaw is active.

Publication


Featured researches published by John R. Votaw.


Brain Research | 1993

Identification of extrastriatal dopamine D2 receptors in post mortem human brain with [125I]epidepride

Robert M. Kessler; William O. Whetsell; M. Sib Ansari; John R. Votaw; Tomas de Paulis; Jeffrey A. Clanton; Dennis E. Schmidt; N. Scott Mason; Ronald G. Manning

The regional distribution of striatal and extrastriatal dopamine D2 receptors in human brain was studied in vitro with (S)-N-[(1-ethyl-2- pyrrolidinyl)methyl]-5-[125I]iodo-2,3-dimethoxybenzamide, [125I]epidepride, using post mortem brain specimens from six subjects. Scatchard analysis of the saturation equilibrium binding in twenty-three regions of post mortem brain revealed highest levels of binding in the caudate (16.5 pmol/g tissue) and putamen (16.6 pmol/g tissue) with lower levels seen in the globus pallidus (7.0 pmol/g tissue), nucleus accumbens (7.2 pmol/g tissue), hypothalamus (1.8 pmol/g tissue), pituitary (1.3 pmol/g tissue), substantia innominata (1.0 pmol/g tissue), and amygdala (0.87 pmol/g tissue). Of note was the presence of dopamine D2 receptors in the four thalamic nuclei studied, i.e. anterior nucleus (1.0 pmol/g tissue), dorsomedial nucleus (0.96 pmol/g tissue), ventral nuclei (0.72 pmol/g tissue), and pulvinar (0.86 pmol/g tissue), at levels comparable to the amygdala (0.87 pmol/g tissue) and considerably higher than levels seen in anterior cingulate (0.26 pmol/g tissue) or anterior hippocampus (0.36 pmol/g tissue). The frontal cortex had very low levels of dopamine D2 receptors (0.17-0.20 pmol/g tissue) while the inferior and medial temporal cortex had relatively higher levels (0.31-0.46 pmol/g tissue). Inhibition of [125I]epidepride binding by a variety of neurotransmitter ligands to striatal, ventral thalamic and inferior temporal cortical homogenates demonstrated that [125I]epidepride binding was potently inhibited only by dopamine D2 ligands. The present study demonstrates that dopamine D2 receptors are present in basal ganglia, many limbic regions, cortex and in the thalamus. The density of thalamic D2 receptors is comparable to many limbic regions and is considerably higher than in cortex.(ABSTRACT TRUNCATED AT 250 WORDS)


European Journal of Pharmacology | 1992

Visualization of extrastriatal dopamine D2 receptors in the human brain

Robert M. Kessler; N. Scott Mason; John R. Votaw; Tomas de Paulis; Jeffrey A. Clanton; M. Sib Ansari; Dennis E. Schmidt; Ronald G. Manning; Robert L. Bell

[123I]Epidepride, a potent and selective dopamine D2 radioligand, was administered to a 27 year old normal male volunteer. Single photon tomography revealed that peak striatal uptake occurred at 4 h after injection with a striatal:cerebellar ratio of 7.8 rising to over 100 at 18 h post injection. Uptake above the levels seen in cerebellum was also noted in the thalamus, pituitary, hypothalamus and temporal lobe, particularly medially. Single photon tomography with [123I]epidepride allows visualization of extrastriatal dopamine D2 receptors in man.


Life Sciences | 1993

High affinity dopamine D2 receptor radioligands. 3. [123I] and [125I]epidepride: In vivo studies in rhesus monkey brain and comparison with in vitro pharmacokinetics in rat brain

Robert M. Kessler; John R. Votaw; Dennis E. Schmidt; M. Sib Ansari; Karen P. Holdeman; Tomas de Paulis; Jeffrey A. Clanton; Rhonda Pfeffer; Ronald G. Manning; Michael H. Ebert

Studies of [123I]epidepride uptake in rhesus monkey brain were performed using single photon tomography. Striatal uptake peaked at 0.85% of administered dose/g at 107 min post-injection, then declined slowly to 0.70% of administered dose/g at 6 h. Striatal:posterior brain ratios rose from 2 at 25 min to 6.8 at 105 min, to 15 at 4 h and to 58 at 6.4 h. [123I]Epidepride was displaced by haloperidol (0.1 and 1 mg/kg) with a half-life of washout of 55 min. Little displacement of [123I]epidepride was observed following administration of 1 or 2 mg/kg d-amphetamine, respectively, indicating [123I]epidepride is not easily displaced by endogenous dopamine. In vitro equilibrium binding studies using rat striatum revealed a KD of 46 pM and Bmax of 33 pmol/g tissue at 37 degrees C, while at 25 degrees C the KD was 25 pM and the Bmax 32 pmol/g tissue. In vitro kinetic analysis of association and dissociation curves revealed a half-life for receptor dissociation at 37 degrees C of 15 min and 79-90 min at 25 degrees C. Allowing for the temperature difference, there is good correspondence between in vivo and in vitro dissociation kinetics at 25 degrees C. Increasing in vitro incubation temperature from 25 to 37 degrees C caused a 6-fold increase in the dissociation rate, suggesting that there is a change in binding kinetics at the dopamine D2 receptor at 37 degrees C compared to in vivo binding. The results of this study indicate that [123I]epidepride is an excellent radioligand for SPECT studies of the dopamine D2 receptor in man.


The Annals of Thoracic Surgery | 1993

Noninvasive detection of acute rejection in a new experimental model of heart transplantation

Steven J. Hoff; James R. Stewart; William H. Frist; James B. Atkinson; Marvin W. Kronenberg; John R. Votaw; Robert M. Kessler; Martin P. Sandler

We have shown that positron emission scintigraphy detects changes in the uptake of 18-F 2-deoxyglucose and 13-N ammonia by the acutely rejecting myocardium in a nonworking model of heterotopic heart transplantation in the rat. We developed a new working model of heterotopic heart transplantation to determine the possible relevance of these changes to clinical transplantation. Moderate aortic valvular regurgitation was produced allowing the heterotopic left ventricle to fill and eject. Rejecting allografts and nonrejecting isografts (controls) were studied 4 days after transplantation. Histologically, isografts were normal and all allografts showed mild acute rejection. Decay-corrected uptakes of 18-F 2-deoxyglucose and 13-N ammonia reflect glucose metabolism and blood flow, respectively. Values are presented as percent of injected dose per gram of tissue. Uptake of 18-F 2-deoxyglucose was higher in rejecting allografts compared with nonrejecting isografts (3.0 +/- 1.8 versus 1.1 +/- 0.4; p = 0.024). Ammonia uptake was elevated in allografts compared with isografts (2.2 +/- 0.5 versus 1.3 +/- 0.5; p = 0.023). Uptakes of 18-F 2-deoxyglucose and 13-N ammonia are higher in mildly rejecting allografts, implying increased glucose utilization and blood flow during acute rejection. These data support our earlier findings of changes in myocardial metabolism in the absence of diminishing blood flow in acutely rejecting hearts. This model may lead to a better understanding of the physiology and metabolism of acute rejection.


The Annals of Thoracic Surgery | 1992

Noninvasive detection of heart transplant rejection with positron emission scintigraphy

Steven J. Hoff; James R. Stewart; William H. Frist; Robert M. Kessler; Martin P. Sandler; James B. Atkinson; John R. Votaw; John A. Carey; M. Sib Ansari; Walter H. Merrill

Positron emission tomography has recently been used to evaluate ischemic heart disease through changes in myocardial blood flow and carbohydrate metabolism. Positron-emitting tracers were evaluated for their ability to detect acute allograft rejection after heterotopic cardiac transplantation in the rat. Sham-operated controls, nonrejecting isografts, and rejecting allografts were evaluated. Decay-corrected uptake of 13NH3 and 18F 2-fluoro 2-deoxyglucose (FDG) reflects blood flow and glucose flux, respectively. Histologic examination of rejecting allografts documented mild rejection at 4 days and severe acute rejection by 8 days. All isografts were free from rejection. Uptake of FDG is greater in rejecting allografts than in nonrejecting isografts during both severe rejection (2.4% +/- 0.8% versus 0.7% +/- 0.4%; p less than 0.02) and mild rejection (2.1% +/- 0.6% versus 0.4% +/- 0.1%; p less than 0.02). Uptake of NH3 in severely rejected grafts is reduced compared with nonrejecting grafts (0.6% +/- 0.3% versus 1.7% +/- 1.1%; p less than 0.02). There is no difference in NH3 uptake during mild rejection (1.8% +/- 0.7% versus 1.3% +/- 0.3%; p greater than 0.05). Uptake of FDG and NH3 in native hearts of animals from all experimental groups is not significantly different from that in sham-operated controls. Glucose may be a preferred metabolic substrate during rejection. Our data support a humoral mechanism for substrate preference during transplant rejection and a potential diagnostic role for positron emission tomography.


Medical Imaging VI: Image Processing | 1992

Reformatting PET images by direct fitting of the proportional grid system: implementation and validation

Yaorong Ge; John R. Votaw; Richard A. Margolin; J. Michael Fitzpatrick; Robert J. Maciunas; Robert M. Kessler

An important application of positron emission tomography (PET) is the correlation of patterns of regional brain metabolism with functional and behavioral abnormalities in various deceases. This requires examination of a large number of scans from many subjects, an activity which is facilitated by using a standard coordinate system for image representation. Talairachs proportional grid system is a popular and suitable system for this purpose. It relies on correct localization of the mid-sagittal plane and the line passing through the anterior commissure (AC) and posterior commissure (PC) in the image volume. These structures, however, have not been readily identifiable in PET images. With the increasing resolution of PET scanners, though, it may now be possible to establish the position of the AC-PC line by directly fitting it from anatomical landmarks which are recognizable in PET images and have definite relationships to the AC and PC. This approach is appealing for both practical and technical reasons. In this paper we present an improved method for direct fitting of the AC-PC line and mid-sagittal plane. We evaluate the quality of the approximation in terms of its precision and accuracy, and also assess accuracy by direct comparison with independently registered magnetic resonance (MR) images.


Journal of Pharmaceutical Sciences | 1994

Aromatic and Amine Substituent Effects on the Apparent Lipophiiicities of N-[(2-Pyrrolidinyl)methyl]-Substituted Benzamides

Dennis E. Schmidt; Robert M. Kessler; Tomas de Paulis; John R. Votaw


Synapse | 1993

Evaluation of 5‐[18F]Fluoropropylepidepride as a potential pet radioligand for imaging dopamine D2 receptors

Robert M. Kessler; John R. Votaw; Tomas de Paulis; Daniel R. Bingham; M. Sib Ansari; N. Scott Mason; George E. Holburn; Dennis E. Schmidt; Delicia Votaw; Ronald G. Manning; Michael H. Ebert


Synapse | 1993

Failure of the three compartment model to describe the pharmacokinetics in brain of a high affinity substituted benzamide

John R. Votaw; Robert M. Kessler; Tomas de Paulis


The Journal of Nuclear Medicine | 1995

Dosimetry of Iodine-123-Epidepride: A Dopamine D2 Receptor Ligand

John R. Votaw; Mohammad Sib Ansari; Ns Mason; Dennis E. Schmidt; T. De Paulis; George E. Holburn; Jeffrey A. Clanton; Delicia Votaw; Ronald G. Manning; Robert M. Kessler

Collaboration


Dive into the John R. Votaw's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

N. Scott Mason

University of Pittsburgh

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

James B. Atkinson

Vanderbilt University Medical Center

View shared research outputs
Researchain Logo
Decentralizing Knowledge